pep503
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02465593)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pep503
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02901483 | Phase 1/Phase 2 (Phase 2) | Oct 11, 2016 | Chang Gung University, PharmaEngine |
| NCT02465593 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2015 | Kaohsiung Medical University, PharmaEngine |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmaEngine | For profit | 2 | 2 | 1 | 2015 |
| Chang Gung University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Kaohsiung Medical University | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1